Symmetry Partners, LLC Gilead Sciences, Inc. Transaction History

Symmetry Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$63.15 - $72.88 $128,636 - $148,456	2,037 Added 18.51%	13,041 $895,000
Q4 2023 Jan 02, 2024	SELL	$73.27 - $83.09 $778,420 - $882,748	-10,624 Reduced 49.12%	11,004 $893,000
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $114,237 - $124,635	-1,545 Reduced 6.67%	21,628 $1.62 Million
Q4 2022 Jan 06, 2023	BUY	$62.32 - $89.47 $446,273 - $640,694	7,161 Added 44.72%	23,173 $1.99 Million
Q3 2022 Oct 03, 2022	SELL	$59.54 - $68.01 $53,705 - $61,345	-902 Reduced 5.33%	16,012 $988,000
Q2 2022 Jul 11, 2022	BUY	$57.72 - $65.01 $62,337 - $70,210	1,080 Added 6.82%	16,914 $1.05 Million
Q1 2022 Apr 04, 2022	BUY	$57.92 - $72.58 $72,747 - $91,160	1,256 Added 8.62%	15,834 $941,000
Q2 2021 Jul 07, 2021	BUY	$63.47 - $69.35 $18,279 - $19,972	288 Added 2.02%	14,578 $1 Million
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $23,760 - $27,110	-396 Reduced 2.7%	14,290 $924,000
Q4 2020 Feb 18, 2021	SELL	$56.65 - $64.55 $28,325 - $32,275	-500 Reduced 3.29%	14,686 $856,000
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $189,901 - $238,768	3,058 Added 25.21%	15,186 $960,000
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $877,339 - $1.02 Million	12,128 New	12,128 $933,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.